Spots Global Cancer Trial Database for Minimize Radioactive Iodine Ablation Of Remnant Thyroid in Differentiated Thyroid Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Minimize Radioactive Iodine Ablation Of Remnant Thyroid in Differentiated Thyroid Cancer
Official Title: Phase Ⅱ Non-randomized Multicenter Controlled Trial About Effect of Remnant Ablation Therapy on the Recurrence in Low-risk Differentiated Thyroid Cancer Patients
Study ID: NCT02418247
Conditions
Study Description
Brief Summary: The researchers investigated the rate of biochemical remission in patients without radioactive iodine therapy compared to patients with low dose radioactive iodine treatment in differentiated thyroid cancer patients who underwent total thyroidectomy.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Chungnam National University Hospital, Daejun, , Korea, Republic of
National Cancer Center, Korea, Goyang, , Korea, Republic of
Seoul National University Boramae Medical Center, Seoul, , Korea, Republic of
Seoul National University Hospital, Seoul, , Korea, Republic of
Seoul National University Bundang Hospital, Sungnam, , Korea, Republic of
Contact Details
Name: Eun Kyung Lee, M.D.,Ph.D.
Affiliation: National Cancer Center, Korea
Role: STUDY_CHAIR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
